NEUROENDOCRINE TUMORS
Clinical trials for NEUROENDOCRINE TUMORS explained in plain language.
Never miss a new study
Get alerted when new NEUROENDOCRINE TUMORS trials appear
Sign up with your email to follow new studies for NEUROENDOCRINE TUMORS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Radioactive drug targets hard-to-treat neuroendocrine tumors in early trial
Disease control Not yet recruitingThis phase 1 trial tests a radioactive drug called 211At-MABG in 16 adults with advanced neuroendocrine cancers, including pheochromocytoma and paraganglioma. The drug delivers radiation directly to cancer cells that show up on a special scan. The main goal is to see if the treat…
Matched conditions: NEUROENDOCRINE TUMORS
Phase: PHASE1 • Sponsor: University of Pennsylvania • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
New imaging agent could improve detection of rare cancers
Diagnosis Not yet recruitingThis study will compare a new radioactive tracer, 18F-AmBF3TATE, to the standard tracer 68Ga-DOTATATE for PET scans in people with neuroendocrine tumors. The goal is to see if the new tracer is as good or better at finding tumors. About 51 participants will receive both tracers a…
Matched conditions: NEUROENDOCRINE TUMORS
Sponsor: British Columbia Cancer Agency • Aim: Diagnosis
Last updated Jun 27, 2026 13:01 UTC
-
New PET scan could sharpen detection of neuroendocrine tumors
Diagnosis Not yet recruitingThis study will test a new type of PET scan using a radioactive tracer called 18F-Octreotide in 152 people with or suspected of having neuroendocrine tumors. The goal is to see if this scan can more accurately locate tumors, guide treatment decisions, and help predict how the dis…
Matched conditions: NEUROENDOCRINE TUMORS
Sponsor: First Affiliated Hospital of Zhejiang University • Aim: Diagnosis
Last updated Jun 27, 2026 08:07 UTC
-
New registry aims to unlock secrets of rare heart disease from gut tumors
Knowledge-focused Not yet recruitingThis study will create a registry of about 120 patients in Poland who have carcinoid heart disease, a rare complication of neuroendocrine tumors that damages heart valves. Researchers will collect medical records, echocardiograms, and lab results to better understand who develops…
Matched conditions: NEUROENDOCRINE TUMORS
Sponsor: National Institute of Cardiology, Warsaw, Poland • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:11 UTC